| 1 | [SID865579] | Active | Potency | 0.8492 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 0.8492 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 2 | [SID865579] | Active | AC50 | 1.478 | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity [AID493248, Type: confirmatory] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | AC50 | 1.478 [uM] | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity | | AID | 493248 | | BioAssay type | confirmatory | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 3 | [SID865579] | Active | EC50 | 1.667 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | EC50 | 1.667 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID865579] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID865579] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID865579] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID865579] | Active | AC50 | 3.746 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | AC50 | 3.746 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID865579] | Active | AC50 | 4.247 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | AC50 | 4.247 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID865579] | Active | Potency | 6.3096 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 10 | [SID865579] | Active | Potency | 10 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 11 | [SID865579] | Active | Potency | 10 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 12 | [SID865579] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID865579] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID865579] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID865579] | Active | Potency | 12.5893 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 16 | [SID865579] | Active | Potency | 12.5893 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 17 | [SID865579] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 18 | [SID865579] | Active | Potency | 79.4328 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 19 | [SID865579] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 20 | [SID865579] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 21 | [SID865579] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 22 | [SID865579] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID865579] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID865579] | Active | | | Cell Proliferation & Viability (Cytotoxicity) Primary Assay 60K MLSMR [AID463, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Cell Proliferation & Viability (Cytotoxicity) Primary Assay 60K MLSMR | | AID | 463 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID865579] | Active | | | Allosteric Modulators of D1 Receptors: Primary Screen [AID641, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Allosteric Modulators of D1 Receptors: Primary Screen | | AID | 641 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID865579] | Active | | | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm [AID709, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm | | AID | 709 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID865579] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID865579] | Active | | | Counter Screen for Luciferase-based Primary Inhibition Assays [AID1006, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Counter Screen for Luciferase-based Primary Inhibition Assays | | AID | 1006 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID865579] | Active | | | Identification of compounds which are cytotoxic to PPC-1 cells. [AID1447, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Identification of compounds which are cytotoxic to PPC-1 cells. | | AID | 1447 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID865579] | Active | | | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. [AID1486, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. | | AID | 1486 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID865579] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID865579] | Active | | | Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line. [AID1825, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line. | | AID | 1825 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID865579] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_3, Type: other] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 34 | [SID865579] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_3, Type: other] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 35 | [SID865579] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 36 | [SID865579] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 37 | [SID865579] | Active | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 38 | [SID865579] | Active | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 39 | [SID865579] | Active | | | Fluorescence-based counterscreen for antagonists of the G-protein coupled receptor 7 (GPR7): cell-based high throughput screening assay to identify antagonists of the melanin-concentrating hormone receptor 1 (MCHR1). [AID2148, Type: screening] | melanin-concentrating hormone receptor 1 [Homo sapiens] [gi:88758590] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for antagonists of the G-protein coupled receptor 7 (GPR7): cell-based high throughput screening assay to identify antagonists of the melanin-concentrating hormone receptor 1 (MCHR1). | | AID | 2148 | | BioAssay type | screening | | Target | melanin-concentrating hormone receptor 1 [Homo sapiens] [gi:88758590] | | PubMed | | | Data Table |  |
|
| 40 | [SID865579] | Active | | | Fluorescence-based counterscreen for antagonists of the G-protein coupled receptor 7 (GPR7): cell-based high throughput screening assay to identify antagonists of the melanin-concentrating hormone receptor 1 (MCHR1). [AID2148, Type: screening] | melanin-concentrating hormone receptor 1 [Homo sapiens] [gi:88758590] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for antagonists of the G-protein coupled receptor 7 (GPR7): cell-based high throughput screening assay to identify antagonists of the melanin-concentrating hormone receptor 1 (MCHR1). | | AID | 2148 | | BioAssay type | screening | | Target | melanin-concentrating hormone receptor 1 [Homo sapiens] [gi:88758590] | | PubMed | | | Data Table |  |
|
| 41 | [SID865579] | Active | | | Counterscreen for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) [AID695, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Counterscreen for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) | | AID | 695 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 42 | [SID865579] | Active | | | Counterscreen for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) [AID695, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Counterscreen for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) | | AID | 695 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 43 | [SID865579] | Active | | | Counterscreen for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) [AID695, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Counterscreen for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) | | AID | 695 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 44 | [SID865579] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_1, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 45 | [SID865579] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_1, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 46 | [SID865579] | Active | | | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. [AID1497, Type: screening] | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. | | AID | 1497 | | BioAssay type | screening | | Target | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] | | PubMed | | | Data Table |  |
|
| 47 | [SID865579] | Active | | | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. [AID1497, Type: screening] | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. | | AID | 1497 | | BioAssay type | screening | | Target | integrin alpha-M isoform 2 precursor [Homo sapiens] [gi:88501734] | | PubMed | | | Data Table |  |
|
| 48 | [SID865579] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 49 | [SID865579] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 50 | [SID865579] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 865579 | | CID | 666838 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|